These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 11369253)
1. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Galanis E; Vile R; Russell SJ Crit Rev Oncol Hematol; 2001 Jun; 38(3):177-92. PubMed ID: 11369253 [TBL] [Abstract][Full Text] [Related]
3. Cytolytic viruses as potential anti-cancer agents. Ring CJA J Gen Virol; 2002 Mar; 83(Pt 3):491-502. PubMed ID: 11842243 [TBL] [Abstract][Full Text] [Related]
4. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
5. Targeting strategies in cancer gene therapy. Wang JH; Liu XY Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383 [TBL] [Abstract][Full Text] [Related]
6. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). Bauerschmitz GJ; Barker SD; Hemminki A Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964 [TBL] [Abstract][Full Text] [Related]
7. Viral vectors for cancer gene therapy: viral dissemination and tumor targeting. Jia W; Zhou Q Curr Gene Ther; 2005 Feb; 5(1):133-42. PubMed ID: 15638717 [TBL] [Abstract][Full Text] [Related]
10. Selective replicating viral vectors : potential for use in cancer gene therapy. Nemunaitis J BioDrugs; 2003; 17(4):251-62. PubMed ID: 12899642 [TBL] [Abstract][Full Text] [Related]
11. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Freytag SO; Rogulski KR; Paielli DL; Gilbert JD; Kim JH Hum Gene Ther; 1998 Jun; 9(9):1323-33. PubMed ID: 9650617 [TBL] [Abstract][Full Text] [Related]
12. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Harrington K; Alvarez-Vallina L; Crittenden M; Gough M; Chong H; Diaz RM; Vassaux G; Lemoine N; Vile R Hum Gene Ther; 2002 Jul; 13(11):1263-80. PubMed ID: 12162810 [TBL] [Abstract][Full Text] [Related]
16. Non-viral vectors in cancer gene therapy: principles and progress. Schatzlein AG Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785 [TBL] [Abstract][Full Text] [Related]
17. An overview of current delivery systems in cancer gene therapy. El-Aneed A J Control Release; 2004 Jan; 94(1):1-14. PubMed ID: 14684267 [TBL] [Abstract][Full Text] [Related]
18. Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors. Rots MG; Curiel DT; Gerritsen WR; Haisma HJ J Control Release; 2003 Feb; 87(1-3):159-65. PubMed ID: 12618032 [TBL] [Abstract][Full Text] [Related]
19. Replicating adenoviruses in cancer therapy. Dobbelstein M Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605 [TBL] [Abstract][Full Text] [Related]